USPTO 2015–2025 USPTO PatentsView US Corporation

OCV Intellectual Capital, LLC

USPTO PatentsView assignee record - 31 granted patents across 32 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C03C (Chemical Composition OF Glasses, Glazes OR Vitreous ENAMELS; Surface Treatment OF GLASS; Surface Treatment OF Fibres OR Filaments Made From Glass, Minerals OR SLAGS; Joining Glass TO Glass OR Other MA).

RSS updates for this company

The verdict

According to USPTO PatentsView, OCV ranks #10,125 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 32 technology areas.

#10,125
of 49,997 US assignees by volume
Top 32%
by Innovation Score (41.9/100)
16.6
avg claims per patent
-93%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10125 · US Corporation #10,125 · 31 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 31 grants
  • UPPER-Q #10,125/49,997
  • PHOTO-FINISH Novo Nordisk Health…
  • CPC-FOCUS C03C · 32 areas
  • INNOV-PAR 41.9/100
  • CLAIMS-RICH 16.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -93% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Novo Nordisk Health Care AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around OCV

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows OCV's Innovation Score is 41.9/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where OCV's grants concentrate

OCV Intellectual Capital, LLC is a focused PatentsView assignee: 32 CPC subclasses with 54.8% of grants classified under C03C (Chemical Composition OF Glasses, Glazes OR Vitreous ENAMELS; Surface Treatment OF GLASS; Surface Treatment OF Fibres OR Filaments Made From Glass, Minerals OR SLAGS; Joining Glass TO Glass OR Other MA). Peak complete grant year is 2017 (8 grants) versus a trough of 1 in 2020. By volume, OCV sits between Novo Nordisk Health Care AG and PIC Corporation.

Who files at OCV's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows OCV holds 31 patents at rank #10,125, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near OCV

By rank, the assignees closest to #10,125 in granted patent volume.

Leaders in C03C (Chemical Composition OF Glasses)

Other assignees with the most granted patents in OCV's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for OCV, neither rank-band nor same-CPC leaders (those blocks stay above).

OCV's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2015201620172018201920202021 1
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
OCV Intellectual Capital, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 6 19.4%
2016 6 19.4%
2017 8 25.8%
2018 6 19.4%
2019 3 9.7%
2020 1 3.2%
2021 1 3.2%

Which technologies does OCV Intellectual Capital, LLC patent most?

Top 15 of 32 technology areas

Where it ranks

Overall rank by patents

#10,125

of 49,997 tracked assignees

Innovation Score

41.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

OCV Intellectual Capital, LLC's patent record in context - here's where to go next.

  • OCV Intellectual Capital, LLC's lead technology class is C03C (Chemical Composition OF Glasses, Glazes OR Vitreous ENAMELS; Surface Treatment OF GLASS; Surface Treatment OF Fibres OR Filaments Made From Glass, Minerals OR SLAGS; Joining Glass TO Glass OR Other MA), 54.8% of its portfolio - see every assignee active in that class. Explore C03C
  • Ranked #10,125 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare OCV Intellectual Capital, LLC against Novo Nordisk Health Care AG, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 41.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.